Clopidogrel increases risk of MACE in patients with CYP2C19 LoF alleles

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2025年 / 2047卷 / 1期
关键词：
D O I：
10.1007/s40278-025-77792-8
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：7 / 7
相关论文
共 50 条
  • [21] Pharmacogenomic evaluation of CYP2C19 alleles linking low clopidogrel response and the risk of acute coronary syndrome in Indians
    Bhat, Keshavamurthy Ganapathy
    Pillai, Ratheesh Kumar Janardhana
    Lodhi, Heemanshu
    Guleria, Vivek Singh
    Abbot, Anil Kumar
    Gupta, Love
    Rastogi, Garima
    Sharma, Anuka
    Mohammed, Zafar
    Sharma, Varun
    JOURNAL OF GENE MEDICINE, 2024, 26 (01):
  • [22] The effect of CYP2C19*2 polymorphism on clopidogrel resistance in COPD patients
    Kilik, Zeliha Funda
    Akalin, Hilal
    Bayramov, Ruslan
    Erdem, Yakut
    Dundar, Munis
    JOURNAL OF BIOTECHNOLOGY, 2017, 256 : S80 - S80
  • [23] CYP2C19 Genotype and Outcomes of Clopidogrel Treatment
    Geisler, Tobias
    Bigalke, Boris
    Schwab, Matthias
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (05): : 481 - 481
  • [24] The Metabolism of Clopidogrel: CYP2C19 Is a Minor Pathway
    Ford, Neville F.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2016, 56 (12): : 1474 - 1483
  • [25] Efficacy of clopidogrel for stroke depends on CYP2C19 genotype and risk profile
    Xu, Jie
    Wang, Anxin
    Wangqin, Runqi
    Mo, Jinglin
    Chen, Zimo
    Dai, Liye
    Meng, Xia
    Zhao, Xingquan
    Wang, Yilong
    Li, Hao
    Chen, Wei
    Xian, Ying
    Wang, Yongjun
    ANNALS OF NEUROLOGY, 2019, 86 (03) : 419 - 426
  • [26] Prevalence of CYP2C19*2 and CYP2C19*3 Allelic Variants and Clopidogrel Use in Patients with Cardiovascular Disease in Trinidad & Tobago
    Daniele Jones
    Shana Persad-Ramdeensingh
    Sheherazade Crystal Abrahim
    Naveen Seecheran
    Rajini Rani Haraksingh
    Cardiology and Therapy, 2024, 13 : 191 - 203
  • [27] Prevalence of CYP2C19*2 and CYP2C19*3 Allelic Variants and Clopidogrel Use in Patients with Cardiovascular Disease in Trinidad & Tobago
    Jones, Daniele
    Persad-Ramdeensingh, Shana
    Abrahim, Sheherazade Crystal
    Seecheran, Naveen
    Haraksingh, Rajini Rani
    CARDIOLOGY AND THERAPY, 2024, 13 (01) : 191 - 203
  • [28] Identification of new human CYP2C19 alleles (CYP2C19*6 and CYP2C19*2B) in a Caucasian poor metabolizer of mephenytoin
    Ibeanu, GC
    Goldstein, JA
    Meyer, U
    Benhamou, S
    Bouchardy, C
    Dayer, P
    Ghanayem, BI
    Blaisdell, J
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1998, 286 (03): : 1490 - 1495
  • [29] FREQUENCY OF CYP2C19 VARIANT ALLELES IN KOREANS
    Hong, Seong-Kuk
    Choi, Min-Je
    Bae, Jung-Woo
    DRUG METABOLISM AND PHARMACOKINETICS, 2017, 32 (01) : S87 - S87
  • [30] Assessment of CYP2C19 genetic polymorphisms in a korean population using a simultaneous multiplex pyrosequencing method to simultaneously detect the CYP2C19*2, CYP2C19*3, and CYP2C19*17 alleles
    Kim, K. -A.
    Song, W. -K.
    Kim, K. -R.
    Park, J. -Y.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2010, 35 (06) : 697 - 703
12345